68 vacatures voor Johnson & Johnson in Nederland (2024)

FAQs

How did Johnson and Johnson became successful? ›

Inventive machines and dedicated employees drove the company's rapid growth. By the turn of the 20th century, successive waves of immigrants, many from Hungary, became the backbone of Johnson & Johnson's workforce.

Every day, our more than 130,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal. At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.

J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits. A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.

The company is a producer of medical devices and pharmaceuticals, and the owner of many well- known consumer brands (such as Band-Aid, Aveeno, Reach, Splenda, Tylenol, Zyrtec, etc.). The company has 128,700 employees worldwide, and total annual revenue exceeding $70 billion.

Johnson & Johnson's Development

Among other achievements, the company produced the first cheap, commonly available sanitary menstrual pads for women, the first mass-produced dental floss, and some of the first oil, powder and shampoo for babies and infants.

Johnson & Johnson's success is due to a number of factors, including its strong brand reputation, diversified product portfolio, global reach, strong commitment to research and development, and strong financial performance. Johnson & Johnson is one of the most trusted and respected brands in the world.

The ownership structure of Johnson & Johnson (JNJ) stock is a mix of institutional, retail and individual investors. Approximately 54.53% of the company's stock is owned by Institutional Investors, 0.19% is owned by Insiders and 45.28% is owned by Public Companies and Individual Investors.

Johnson is a surname and given name of Anglo-Norman origin, meaning “son of John.” The name John derives from Yochanan, a Hebrew name meaning “God is gracious.” Johnson is the second most common surname in the United States, and ranks at 154th most common in the world.

J&J's financial results are considered a bellwether for the broader health sector. The company posted $21.38 billion in total sales for the first three months of 2024, up more than 2% from the same quarter in 2023. The pharmaceutical giant booked net income of $5.35 billion, or $2.20 per share during the quarter.

Those efforts range from a $50 million commitment to support programs aimed at helping front line healthcare workers to research on an investigational COVID-19 vaccine candidate that's currently in Phase 3 clinical trials.

What are the core values of Johnson and Johnson? ›

Core Values

"Growth & innovation, investing in the future, global diversity, citizenship and sustainability, developing diversity, and global supply base" are among Johnson & Johnson's fundamental principles. This business has shown that it cares about people and their well-being.

The name Kenvue reflects J&J's desire for the new consumer company identity to take a backseat to well-known brands. This is a similar strategy to other consumer product conglomerates such as Unilever, the owner of Dove and Hellmann's, and Procter & Gamble, which owns Bounty and Charmin.

We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

After taking office, he won passage of a major tax cut, the Clean Air Act, and the Civil Rights Act of 1964. After the 1964 election, Johnson passed even more sweeping reforms. The Social Security Amendments of 1965 created two government-run healthcare programs, Medicare and Medicaid.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.

A booster at two months showed that a second shot of the J&J COVID-19 vaccine given 56 days after the first provided 100% protection (CI, 33–100%) against severe/critical COVID-19–at least 14 days post-final vaccination; 75% protection against symptomatic (moderate to severe/critical) COVID-19 globally (CI, 55–87%); ...